Joe Nolan, Jaguar CEO (Jaguar)
April 13, 2021 08:49 AM EDTUpdated 09:01 AM
Financing

Jaguar, Sean Nolan's lat­est biotech, rais­es $139M as they fol­low Taysha's foot­steps

Jason Mast

Editor

Joe Nolan swears he isn’t try­ing to hur­tle Jaguar Gene Ther­a­py to­ward a 0-to-60 IPO, but it sure looks like it.

Less than two months …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times